PubMed=20360942; DOI=10.1593/neo.91948; PMCID=PMC2847739
Lawrenson K., Grun B., Benjamin E., Jacobs I.J., Dafou D., Gayther S.A.
Senescent fibroblasts promote neoplastic transformation of partially transformed ovarian epithelial cells in a three-dimensional model of early stage ovarian cancer.
Neoplasia 12:317-325(2010)

PubMed=21859834; DOI=10.1093/carcin/bgr140
Lawrenson K., Sproul D., Grun B., Notaridou M., Benjamin E., Jacobs I.J., Dafou D., Sims A.H., Gayther S.A.
Modelling genetic and clinical heterogeneity in epithelial ovarian cancers.
Carcinogenesis 32:1540-1549(2011)

PubMed=25204737; DOI=10.1002/ijc.29197
Lawrenson K., Mhawech-Fauceglia P., Worthington J., Spindler T.J., O'Brien D., Lee J.M., Spain G., Sharifian M., Wang G.-S., Darcy K.M., Pejovic T., Sowter H.M., Timms J.F., Gayther S.A.
Identification of novel candidate biomarkers of epithelial ovarian cancer by profiling the secretomes of three-dimensional genetic models of ovarian carcinogenesis.
Int. J. Cancer 137:1806-1817(2015)

PubMed=25804953; DOI=10.1093/hmg/ddv101; PMCID=PMC4459387
Coetzee S.G., Shen H.C., Hazelett D.J., Lawrenson K., Kuchenbaecker K., Tyrer J.P., Rhie S.K., Levanon K., Karst A.M., Drapkin R.I., Ramus S.J., Couch F.J., Offit K., Chenevix-Trench G., Monteiro A.N.A., Antoniou A., Freedman M.L., Coetzee G.A., Pharoah P.D.P., Noushmehr H., Gayther S.A.
Consortium of Investigators of Modifiers of BRCA1/2
Ovarian Cancer Association Consortium
Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility loci.
Hum. Mol. Genet. 24:3595-3607(2015)

PubMed=29844388; DOI=10.1038/s41598-018-26670-4; PMCID=PMC5974302
Gjyshi A., Dash S., Cen L., Cheng C.-H., Zhang C.-M., Yoder S.J., Teer J.K., Armaiz-Pena G.N., Monteiro A.N.A.
Early transcriptional response of human ovarian and fallopian tube surface epithelial cells to norepinephrine.
Sci. Rep. 8:8291-8291(2018)

PubMed=30487138; DOI=10.1158/0008-5472.CAN-17-3864; PMCID=PMC6359979
Buckley M.A., Woods N.T., Tyrer J.P., Mendoza-Fandino G., Lawrenson K., Hazelett D.J., Najafabadi H.S., Gjyshi A., Carvalho R.S., Lyra P.C. Jr., Coetzee S.G., Shen H.C., Yang A.W., Earp M.A., Yoder S.J., Risch H., Chenevix-Trench G., Ramus S.J., Phelan C.M., Coetzee G.A., Noushmehr H., Hughes T.R., Sellers T.A., Goode E.L., Pharoah P.D.P., Gayther S.A., Monteiro A.N.A.
Functional analysis and fine mapping of the 9p22.2 ovarian cancer susceptibility locus.
Cancer Res. 79:467-481(2019)

PubMed=34253763; DOI=10.1038/s41598-021-93506-z; PMCID=PMC8275603
Dash S., Yoder S.J., Mesa T., Smith A., Cen L., Eschrich S.A., Armaiz-Pena G.N., Monteiro A.N.A.
Effects of long-term norepinephrine treatment on normal immortalized ovarian and fallopian tube cells.
Sci. Rep. 11:14334.1-14334.12(2021)